Micrornas associated to single drug components of r-chop identifies diffuse large b-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index

HIGHLIGHTS

• who: Hanne Due from the Department of Hematology, Aalborg University Hospital, SdrSkovvej, Aalborg, Denmark have published the paper: MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index, in the Journal: (JOURNAL)
• what: Since DLBCL is characterized by great clinical and molecular heterogeneity the purpose of this study was to investigate whether miRNAs associated to single drug components of R-CHOP can improve robustness of individual markers and serve as a prognostic classifier. The study was conducted . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.